Pharmacy World and Science

, Volume 24, Issue 4, pp 120–127 | Cite as

Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc®

  • Marion Schaefer


Coding systems are important tools for the documentation of drug-related problems and following interventions. They should be suitable not only for scientific studies but for the broader implementation of Pharmaceutical Care in the pharmacy. A suitable coding system must be easy to use in daily routine. To facilitate later computer aided use, it should be preferably structured like a decision tree and consist of three parts:1. the classification of drug-related problems2. the intervention taken to solve to problem3. the degree to which the problem was solvedPI-Doc® considers other classification systems used by Hepler and Strand the PAS®-Coding System and draws empirical experience from a study in 1995 and 1998 in Germany. The main groups comprise the following:- unsuitable drug choice- unsuitable use by the patient, incl. compliance- unsuitable dosage- drug—drug interactions- adverse drug reactions - other drug-related problems - patient-related - communication-related - technical and logistic problemsThe article discusses basic principles of the development of a coding system and the prerequisites for its application. In addition, it tries to give guidance for the classification process itself. It is also recommended to collect further information while documenting drug-related problems, in order to allow additional statistical evaluation.

Coding system Drug-related problems Process indicators Quality of care 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Strand I, Morley P, Cipolle R, Ramsey R, Lamsam G. Drug related problems: their structure and functions. DICP, Ann Pharmacother 1990;1093-97.Google Scholar
  2. 2.
    Schaefer M. Wie unentbehrlich sind die Apotheker? Deutsche Apotheker Ztg 1995;3019-27.Google Scholar
  3. 3.
    Chen R, Shalansky SJ. Improving detection of drug-related problems in intensive care with patients. Am J Health Syst Pharm 1996;185-6.Google Scholar
  4. 4.
    Shalansky SJ, Nakagawa R, Wee A. Drug-related problems identified and resolved using Pharmaceutical Care versus traditional clinical monitoring, Can J Hospital Pharmacy 1996;282-8.Google Scholar
  5. 5.
    Winslade NE et al. Pharmacist's management of drug-related problems: a tool for teaching and providing pharmaceutical care. Pharmacotherapy 1997; 801-9.Google Scholar
  6. 6.
    Schaefer M, Kresser J. Pharmazeutische Betreuung vermeidet Schaden. Pharmazeut. Ztg. 1998;4446-54.Google Scholar
  7. 7.
    Westerlund T et al. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Practice 1999;40-50.Google Scholar
  8. 8.
    Westerlund T, Almarsdóttir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm. World and Sci. 2000;245-50.Google Scholar
  9. 9.
    Schaefer M, Braun R. Software für die Pharmazeutische Betreuung. Pharmazeut. Ztg. 1998;3458-64.Google Scholar
  10. 10.
    de Gier JJ. The Electronical Pharmaceutical Dossier, an effective aid to documenting Pharmaceutical Care data. Pharm. Won Sci. 1997;241-3.Google Scholar
  11. 11.
    Assurance: Patient-Centered Pharmaceutical Care. Health Outcomes Management, Inc., Minneapolis, 1999.Google Scholar
  12. 12.
    Berardo DH. Community pharmacist's documentation of intervention on drug-related problems of elderly patients. J Soc Adm Pharm 1994;201-24.Google Scholar
  13. 13.
    van Mil JWF, Tromp, ThFJ. Coding frequently asked questions during the Pharmaceutical Care process with PAS system. J. Appl. Therap 1997;351-5.Google Scholar
  14. 14.
    Kresser J. Analyse und Klassifizierung arzneimittelbezogener Probleme als Beitrag der Apotheker zur Reduzierung anzneimittelbezogener Morbidität und Mortalität. Dissertation, Humboldt-Universität, Berlin 2000.Google Scholar
  15. 15.
    Meyboom RHB, Lindquist M, Egberts ACG. An ABC of Drug-Related Problems. Drug Safety 2000 Jun: 22(6):415-23.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Marion Schaefer
    • 1
  1. 1.Institute of PharmacyHumboldt UniversityBerlinGermany

Personalised recommendations